ACCENDRA HEALTH INC/VA/ (ACH)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 900M 1.8B 2.7B Q2 '16: 2.5B Q3 '16: 2.4B Q4 '16: 2.4B Q1 '17: 2.3B Q2 '17: 2.3B Q3 '17: 2.3B Q4 '17: 2.4B Q1 '18: 2.4B Q2 '18: 2.5B Q3 '18: 2.5B Q4 '18: 2.1B Q1 '19: 2.4B Q2 '19: 2.4B Q3 '19: 2.3B Q4 '19: 2.2B Q1 '20: 2.1B Q2 '20: 1.8B Q3 '20: 2.2B Q4 '20: 2.4B Q1 '21: 2.3B Q2 '21: 2.5B Q3 '21: 2.5B Q4 '21: 2.5B Q1 '22: 2.4B Q2 '22: 2.5B Q3 '22: 2.5B Q4 '22: 2.6B Q1 '23: 2.5B Q2 '23: 2.6B Q3 '23: 2.6B Q1 '24: 2.6B Q2 '24: 660.4M Q3 '24: 686.8M Q4 '24: 695M Q1 '25: 673.9M Q2 '25: 681.9M Q3 '25: 697.3M Q4 '25: 709M Q1 '26: 627.8M Q2 '26: 613.2M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 200M 400M 600M Q2 '15: 298.3M Q3 '15: 306.4M Q4 '15: 312.3M Q1 '16: 296.6M Q2 '16: 299.4M Q3 '16: 296.3M Q4 '16: 295M Q1 '17: 281.2M Q2 '17: 273.5M Q3 '17: 301.9M Q4 '17: 315.2M Q1 '18: 324.7M Q2 '18: 325M Q3 '18: 352.6M Q4 '18: 68.3M Q1 '19: 276.6M Q2 '19: 286.5M Q3 '19: 280.6M Q4 '19: 284.7M Q1 '20: 268.6M Q2 '20: 269.4M Q3 '20: 344.3M Q4 '20: 398.5M Q1 '21: 442.8M Q2 '21: 400.1M Q3 '21: 328.8M Q4 '21: 341.6M Q1 '22: 373.4M Q2 '22: 532.5M Q3 '22: 513.3M Q4 '22: 407.1M Q1 '23: 497.3M Q2 '23: 519.4M Q3 '23: 538.5M Q4 '23: 569.9M Q1 '24: 535.5M Q2 '24: 544.2M Q3 '24: 559.7M Q4 '24: 579.8M Q1 '25: 526M Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25

Operating Income Quarterly

-300M -200M -100M 0 100M 200M 300M Q1 '16: 45M Q2 '16: 52.1M Q3 '16: 53.6M Q4 '16: 49M Q1 '17: 35.5M Q2 '17: 32.8M Q3 '17: 29.7M Q1 '18: 24.2M Q2 '18: -172.1M Q3 '18: 21.4M Q4 '18: -225.9M Q1 '19: 16.6M Q2 '19: 15.9M Q3 '19: 26.1M Q4 '19: 14.5M Q1 '20: 10.8M Q2 '20: 22.2M Q3 '20: 75.6M Q4 '20: 95.6M Q1 '21: 146.7M Q2 '21: 96.9M Q3 '21: 62.9M Q4 '21: 62M Q1 '22: 61.1M Q2 '22: 75.1M Q3 '22: 60.2M Q1 '23: 9.8M Q2 '23: 10.8M Q3 '23: 23.8M Q4 '23: 88.7M Q1 '24: 9.7M Q2 '24: 16.9M Q3 '24: 31.1M Q4 '24: -272.7M Q1 '25: 19.8M Q2 '25: -39.7M Q3 '25: 26.5M Q4 '25: 20.9M Q1 '26: 17.1M Q2 '26: -35.1M Q1 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-900M -600M -300M 0 300M 600M 900M Q2 '16: 27.7M Q3 '16: 29.8M Q4 '16: 27.1M Q1 '17: 18.8M Q2 '17: 20.1M Q3 '17: 10.9M Q4 '17: 23M Q1 '18: 8.2M Q2 '18: -182.8M Q3 '18: -565K Q4 '18: -261.8M Q1 '19: -14.1M Q2 '19: -10.5M Q3 '19: 1.2M Q4 '19: -39M Q1 '20: -11.3M Q2 '20: -55.6M Q3 '20: 46.1M Q4 '20: 50.7M Q1 '21: 69.6M Q2 '21: 65.9M Q3 '21: 44.1M Q4 '21: 42M Q1 '22: 39.3M Q2 '22: 28.6M Q3 '22: 12.5M Q1 '23: -24.4M Q2 '23: -28.2M Q3 '23: -6.4M Q4 '23: 17.8M Q1 '24: -21.9M Q2 '24: -31.9M Q3 '24: -12.8M Q4 '24: -296.1M Q1 '25: -25M Q2 '25: -869.1M Q3 '25: -150.3M Q4 '25: -56.3M Q1 '26: -6.5M Q2 '26: -89.1M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 800M 1.6B 2.4B Q2 '09: 1.8B Q3 '09: 1.8B Q2 '10: 1.8B Q3 '10: 1.9B Q3 '17: 2B Q4 '17: 2.1B Q1 '18: 2B Q2 '18: 2.1B Q3 '18: 2.1B Q4 '18: 2.1B Q1 '19: 2.1B Q2 '19: 2.1B Q3 '19: 2B Q4 '19: 1.9B Q1 '20: 1.9B Q2 '20: 1.5B Q3 '20: 1.8B Q4 '20: 2B Q1 '21: 1.9B Q2 '21: 2.1B Q3 '21: 2.2B Q4 '21: 2.1B Q1 '22: 2B Q2 '22: 2B Q3 '22: 2B Q4 '22: 2.1B Q1 '23: 2B Q2 '23: 2B Q3 '23: 2.1B Q1 '24: 2.1B Q2 '24: 344.4M Q3 '24: 355.1M Q4 '24: 324.4M Q1 '25: 354.6M Q2 '25: 357.3M Q3 '25: 375.1M Q4 '25: 385.7M Q1 '26: 349.8M Q2 '26: 349.8M Q3 '10 Q3 '18 Q4 '19 Q1 '21 Q2 '22 Q3 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-300M -150M 0 150M 300M 450M Q2 '16: -1.9M Q3 '16: 101.3M Q4 '16: 43.2M Q1 '17: -26.4M Q2 '17: -56.1M Q3 '17: 88.1M Q4 '17: 51.1M Q1 '18: 18.3M Q2 '18: 28M Q3 '18: 76.3M Q1 '19: -60.9M Q2 '19: 89.9M Q3 '19: 110.1M Q4 '19: 27M Q1 '20: 93.5M Q2 '20: 57M Q3 '20: 117.7M Q4 '20: 71M Q1 '21: 25.4M Q2 '21: -13M Q3 '21: 61.4M Q4 '21: 50.3M Q1 '22: 79.7M Q2 '22: 89.8M Q3 '22: 68.5M Q4 '22: 87M Q1 '23: 158.4M Q2 '23: 313.1M Q3 '23: 157.4M Q4 '23: 111.8M Q1 '24: -53M Q2 '24: 116.1M Q3 '24: 27.3M Q4 '24: 71M Q1 '25: -35.1M Q2 '25: 37.6M Q3 '25: -172.5M Q4 '25: 68.2M Q1 '26: -50.1M Q2 '26: -26M Q2 '17 Q3 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-300M -200M -100M 0 100M 200M 300M Q2 '16: -5.5M Q3 '16: 96.5M Q4 '16: 36.6M Q1 '17: -36.5M Q2 '17: -62.4M Q3 '17: 79.6M Q4 '17: 41.5M Q1 '18: 11.2M Q2 '18: 15.2M Q3 '18: 63.6M Q1 '19: -72.6M Q2 '19: 80.6M Q3 '19: 99.9M Q4 '19: 15.8M Q1 '20: 88.7M Q2 '20: 53M Q3 '20: 104.8M Q4 '20: 42.3M Q1 '21: 20.4M Q2 '21: -22.6M Q3 '21: 49.6M Q4 '21: 35.8M Q1 '22: 70.1M Q2 '22: 37.2M Q3 '22: 21.5M Q4 '22: 38.1M Q1 '23: 112.2M Q2 '23: 266.5M Q3 '23: 109.7M Q4 '23: 79.9M Q1 '24: -99M Q2 '24: 71.8M Q3 '24: -30.3M Q4 '24: 48.7M Q1 '25: -80.9M Q2 '25: -20M Q3 '25: -246.9M Q4 '25: 55.1M Q1 '26: -91.7M Q2 '26: -73.6M Q2 '17 Q3 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q3 '10: 62.6M Q1 '11: 62.9M Q2 '11: 63.2M Q3 '11: 62.9M Q1 '12: 62.9M Q2 '12: 62.9M Q3 '12: 62.8M Q1 '13: 62.7M Q2 '13: 62.8M Q3 '13: 62.6M Q1 '14: 62.3M Q2 '14: 62.3M Q3 '14: 62.2M Q1 '15: 62.3M Q2 '15: 62.2M Q3 '15: 62M Q1 '16: 61.7M Q2 '16: 61.5M Q3 '16: 61M Q3 '19: 60M Q1 '20: 60.6M Q2 '20: 61.1M Q3 '20: 60.9M Q1 '21: 70.9M Q2 '21: 75.8M Q3 '21: 76M Q1 '22: 76M Q2 '22: 76.3M Q3 '22: 76.4M Q1 '23: 75.2M Q2 '23: 75.8M Q3 '23: 76.2M Q1 '24: 76.3M Q2 '24: 76.7M Q3 '24: 78.5M Q1 '25: 77.3M Q2 '25: 76.9M Q3 '25: 77.3M Q1 '26: 76.4M Q2 '26: 76.7M Q1 '12 Q3 '13 Q2 '15 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q3 '15: 1.36 Q4 '15: 1.65 Q1 '16: 1.74 Q2 '16: 1.80 Q3 '16: 1.83 Q4 '16: 1.76 Q1 '17: 1.68 Q2 '17: 1.56 Q3 '17: 1.26 Q4 '17: 1.20 Q1 '18: 1.02 Q2 '18: -2.38 Q3 '18: -2.57 Q4 '18: -7.31 Q1 '19: -7.67 Q2 '19: -4.77 Q3 '19: -4.74 Q4 '19: -1.02 Q1 '20: -0.98 Q2 '20: -1.72 Q3 '20: -0.98 Q4 '20: 0.47 Q1 '21: 1.64 Q2 '21: 3.42 Q3 '21: 3.24 Q4 '21: 2.99 Q1 '22: 2.53 Q2 '22: 2.03 Q3 '22: 1.61 Q4 '23: -0.53 Q1 '24: -0.50 Q2 '24: -0.55 Q3 '24: -0.63 Q4 '24: -4.73 Q1 '25: -4.76 Q2 '25: -15.64 Q3 '25: -17.42 Q4 '25: -14.32 Q1 '26: -14.08 Q2 '26: -3.94 Q3 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.